Posted: July 14, 2011 at 4:14 pm
Preferred Pain Center is the 1st southwest pain clinic to offer Regenerative Medicine with stem cell injections for pain management. David Greene, MD, CEO, explains the benefits.
Read the original post:
Stem Cell Injections at Arizona's Preferred Pain Management Center (602) 507-6550
Posted: July 13, 2011 at 12:04 am
An Ohio Roman Catholic bishop has told the parishes and schools of his diocese to stop raising money for a national breast cancer charity. Toledo Bishop Leonard Blair said in a letter to priests and parishes over the weekend that he's concerned that Susan G. Komen for the Cure might decide to fund embryonic stem cell research.
Excerpt from:
Bishop Blair bars support for Komen breast cancer group
Posted: July 12, 2011 at 2:03 pm
For the first time in Australia, researchers from University of Melbourne and Monash Institute of Medical Research have converted diseased skin cells into stem cells. Researchers have completed the study by using skin biopsies from patients with the rare genetic disease Friedreich Ataxia (FA). The discovery will allow for the development of new treatments for FA and related conditions such as diabetes and heart disease
Originally posted here:
Visions Episode 92: Stem Cells Discovery
Posted: July 11, 2011 at 3:48 pm
An international team of surgeons have successfully carried out the world's first transplant of a synthetic windpipe at Sweden's Karolinska University Hospital on a 36-year-old man suffering from late stage tracheal cancer. Duration: 00:28
See the article here:
Landmark transplant uses stemcell windpipe
Posted: July 11, 2011 at 2:28 am
BlogTv went wonderful. Thank you to all who showed up. Next time I'll try to give more notice.
The rest is here:
Lupus 7-6-11 a day in life stem cell transplant
Posted: July 11, 2011 at 2:28 am
Eric explains what induced pluripotent stem cells are and how they can help model and treat disease.
See the original post here:
Personalized Medicine: Stem Cells 2/2
Posted: July 10, 2011 at 5:31 pm
CBR is dedicated to collecting the highest volume of cord blood for families because having more stem cells for treatment can improve medical outcomes if the cells are ever needed for transplant. With CBR's exclusive CellAdvantage® system, every detail of CBR's process has been diligently developed, resulting in the best technology available for collecting, processing, and storing a newborn's stem cells.
Continued here:
Newborn Stem Cell Collection Kit Video
Posted: July 10, 2011 at 4:12 pm
in collaboration with:
In an effort to showcase the latest technologies driving the production of cell therapies, the Cell Therapy Group and Informa Life Sciences are proud to announce the introduction of the "Technology Showcase" session and award to be held in conjunction with Informa's Cell Therapy Manufacturing conference to be held 30 November to 1 December 2011 in Brussels Belgium.
Having held the same conference last year in London, Informa is committed to building on the success of last year's event by continuing to create a meaningful European forum for the issues related to the clinical and particularly commercial-scale production of cell-based therapies.
The Technology Showcase session, taking place on the main agenda, will feature 6 x 10 minute presentations from innovative companies developing cutting-edge technologies in the field of cell therapy manufacturing, and is particularly relevant to SME and academic groups with limited marketing resources.
All presentations will be reviewed by the Scientific Advisory Board with the winner announced at the end of the session. Exposure on BioProcess International's website is also included.
Technologies we'd like to promote include:
How to apply:
To apply to present companies must submit an abstract (<300 words) to daniel.barry@informa.com and lbuckler@celltherapygroup.com outlining the product or service to be presented and why it is a critical technology related to cell therapy manufacturing.
The deadline for applications is SEPTEMBER 15 2011 - Priority given to early submissions
The cost of taking part in the Technology Showcase is £2,700 which includes the following benefits:
Terms and conditions:
To be eligible the product or service to be presented must be:
Plus...
For further information please contact: daniel.barry@informa.com or lbuckler@celltherapygroup.com
Posted: July 10, 2011 at 4:10 pm
in collaboration with:
In an effort to showcase the latest technologies driving the production of cell therapies, the Cell Therapy Group and Informa Life Sciences are proud to announce the introduction of the "Technology Showcase" session and award to be held in conjunction with Informa's Cell Therapy Manufacturing conference to be held 30 November to 1 December 2011 in Brussels Belgium.
Having held the same conference last year in London, Informa is committed to building on the success of last year's event by continuing to create a meaningful European forum for the issues related to the clinical and particularly commercial-scale production of cell-based therapies.
The Technology Showcase session, taking place on the main agenda, will feature 6 x 10 minute presentations from innovative companies developing cutting-edge technologies in the field of cell therapy manufacturing, and is particularly relevant to SME and academic groups with limited marketing resources.
All presentations will be reviewed by the Scientific Advisory Board with the winner announced at the end of the session. Exposure on BioProcess International's website is also included.
Technologies we'd like to promote include:
How to apply:
To apply to present companies must submit an abstract (<300 words) to daniel.barry@informa.com and lbuckler@celltherapygroup.com outlining the product or service to be presented and why it is a critical technology related to cell therapy manufacturing.
The deadline for applications is SEPTEMBER 15 2011 - Priority given to early submissions
The cost of taking part in the Technology Showcase is £2,700 which includes the following benefits:
Terms and conditions:
To be eligible the product or service to be presented must be:
Plus...
For further information please contact: daniel.barry@informa.com or lbuckler@celltherapygroup.com
Posted: July 9, 2011 at 7:44 pm
On December 10, 2009, the CIRM Governing Board heard from Dr. Michael Clarke about cancer stems cells. Dr
View original post here:
Spotlight on Cancer Stem Cell Research
